Cancer Core Europe: what has been achieved one year on?
Cancer Core Europe: what has been achieved one year on?
Cancer Core Europe: one year on (full version)
Large B-cell non-Hodgkin’s lymphoma: Optimising therapy for elderly patients
Geonomic testing may help predict metastatic risk after prostatectomy and salvage radiotherapy
Longer duration of ADT after radiotherapy improves disease-free survival in prostate cancer
ECC 2015 scientific highlights
ADT plus docetaxel or bisphosphonates in hormone sensitive prostate cancer: Systemic review
Everolimus for non-functional neuroendocrine tumours
TAT 2016: Targeted anticancer therapies
Round-up of the latest research on lung cancer
Enzalutamide preferable to bicalutamide plus LHRH analogue in prostate cancer
Letrozole vs observation for HR positive breast cancer